ClinicalTrials.gg
Status unknownNCT04501302TraechoUpdated Aug 6, 2020

Effect of Four Exercises on the Inter-recti Distance in Women

An observational study in Diastasis, Muscle, sponsored by APOR B de Gasquet. Status unknown. Open to female participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-08-06.

Sponsored by APOR B de Gasquet · Observational

How we know

The sponsor has not verified this record recently (last verified Aug 2020), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
54
Ages
18 Years to 80 Years
Sex
Female
01

Study summary

Diastasis rectus abdominis (DRA) is defined as an excessive separation between the two abdominal rectus muscles. It is generally quantified by the inter-recti distance. In postpartum women, the prevalence of diastasis is 60% six weeks after delivery.

The increase in the inter-recti distance has been associated with a decrease in strength and endurance of the trunk flexors and rotators (p \< 0.05). Exercise during pregnancy has been shown to be helpful in the treatment of DRA. Nevertheless, there is still not strong evidence to establish what kind of exercise should be recommended during pregnancy and in postpartum.

The aim of this study is to compare the morphological and functional changes of the linea alba during four exercises.

Inter-recti distance, linea alba thickness and distortion index will be measured at rest, as well as during 4 exercises (draw in maneuver, crunch, pelvic floor muscle contraction and a "de Gasquet" exercise). Subgroup analysis will be performed to determine if the presence or absence of an abdominal diastasis has an influence on these outcomes.

A cross-sectional pilot study will be carried out. The main outcome measure will the inter-recti distance. Secondary outcomes will be the thickness of linea alba and distortion index.

02

Conditions studied

  • Diastasis, Muscle

Keywords

  • transversus abdominis, diastasis rectus abdominis, exercise, pelvic floor muscles
03

In context

Diastasis, Muscle

7 studies on the registry are indexed under Diastasis, Muscle; 3 are open to participants now.

Browse Diastasis, Muscle studies →

Lead sponsor

This is the only study on the registry with APOR B de Gasquet as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adult parous women attending to several physiotherapy centers in Paris will be recruited

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults
  • Parous
  • Women
  • Accepting to participe in the research

Exclusion criteria

Exclusion Criteria:

  • Under curatorship
  • Persons deprived of their liberty by judicial or administrative decision
  • Having intellectual limitations that may limit the understanding of questionnaires or exercises
  • With limitations in understanding the French language
  • Pregnant women
  • History of pelvic / spine fractures
  • History of pelvic surgery
  • History of spinal surgery
  • History of abdominal surgery
  • History of lower limbs weakness, changes in osteotendinous reflexes or loss of sensitivity
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
54 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Inter-recti distance

    The distance between the two medial borders of rectus abdominis muscles is measured using ultrasound

    Time frame: During the exercise

Secondary outcomes

  1. Linea alba thickness

    Linea alba thickness is measured using ultrasound

    Time frame: During the exercise

  2. Distortion index of the linea alba

    Average deviation of the linea alba from the shortest path between the recti measured using ultrasound

    Time frame: During the exercise

Other outcomes

  1. Transversus abdominis thickness

    Transversus abdominis thickness at 1cm lateral from the fascia transversalis measured using ultrasound

    Time frame: During the exercise

  2. Current lumbopelvic pain intensity

    Current lumbopelvic pain will be measured using a visual analog scale

    Time frame: During the assessement

  3. Acute lumbopelvic pain severity

    The participants will be asked about their lumbopelvic pain mean intensity in the last week using a visual analog scale

    Time frame: During the assessement

  4. Chronic lumbopelvic pain severity

    The participants will be asked about their lumbopelvic pain mean intensity in the last 6 months using a visual analog scale

    Time frame: During the assessement

  5. Urinary symptoms

    Urinary symptoms will be measured using the Urinary Symptom Profile questionnaires

    Time frame: During the assessement

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2020; primary completion for Feb 2021, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2020
First posted
Aug 6, 2020
StartEst.
Sep 25, 2020
Primary completionEst.
Feb 1, 2021
CompletionEst.
May 1, 2021
Last update
Aug 6, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04501302
Lead sponsor
APOR B de Gasquet
Responsible party
Sponsor
First posted
Aug 6, 2020
Start date
Sep 25, 2020 (estimated)
Primary completion
Feb 1, 2021 (estimated)
Completion
May 1, 2021 (estimated)
Last update
Aug 6, 2020

Study contacts

Montserrat Rejano-Campo, MSc
Contact
montserejano@gmail.com
0033627083914

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion